These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6725869)

  • 1. Multicentric experience on the acute effect of nomifensine in hyperprolactinemic women.
    Minuto F; Barbarino A; Baviera G; Mazzocchi G; De Marinis L; Leonardi R; Bernasconi D; Menini E; Maira G; Anile C
    J Endocrinol Invest; 1984 Apr; 7(2):137-40. PubMed ID: 6725869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors.
    Kamoi K; Tchuchida I; Sato H; Tanaka R; Ishiguro T; Kaneko K; Iwasaki Y; Shibata A
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1285-7. PubMed ID: 7298805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tests of prolactin secretion in the diagnosis of hyperprolactinemic states: nomifensine and domperidone.
    Massara F; Genazzani AR; Camanni F; De Leo V; Molinatti GM; Müller EE
    Fertil Steril; 1981 Feb; 35(2):149-54. PubMed ID: 7202740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomifensine: diagnostic test in hyperprolactinemic states.
    Müller EE; Genazzani AR; Murru S
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1352-7. PubMed ID: 263356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of nomifensine administration to discriminate between tumorous and nontumorous hyperprolactinemia.
    Ferrari C; Crosignani PG; Caldara R; Picciotti MC; Malinverni A; Barattini B; Rampini P; Telloli P
    J Clin Endocrinol Metab; 1980 Jan; 50(1):23-6. PubMed ID: 7188615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of nomifensine on thyroid-stimulating hormone (TSH) in normal and hyperprolactinemic subjects.
    Giusti M; Mazzocchi G; Mignone D; Tarditi W; Contessini M; Bessarione D; Giordano G
    Neuroendocrinology; 1983 Dec; 37(6):406-10. PubMed ID: 6657002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nomifensine on growth hormone and prolactin secretion in normal subjects and in pathological hyperprolactinemia.
    Dallabonzana D; Spelta B; Botalla L; Oppizzi G; Silvestrini F; Chiodini PG; Liuzzi A
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1125-8. PubMed ID: 7076795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of two inhibitory tests (nomifensine and L-dopa + carbidopa) for the diagnosis of hyperprolactinaemic states.
    Moriondo P; Travaglini P; Nissim M; Faglia G
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):525-33. PubMed ID: 7226570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin-releasing effect of domperidone in normoprolactinemic and hyperprolactinemic subjects.
    Camanni F; Genazzani AR; Massara F; La Rosa R; Cocchi D; Müller EE
    Neuroendocrinology; 1980; 30(1):2-6. PubMed ID: 7354887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomifensine, TRH and insulin-induced hypoglycemia tests in the diagnosis of prolactinomas.
    Iannotta F; Fachinetti P; Fachinetti A; Pinotti G; Usellini L
    J Endocrinol Invest; 1983 Oct; 6(5):353-8. PubMed ID: 6420458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disturbed prolactin responses to dopamine-related substances in patients with acromegaly and hyperprolactinemia.
    Sekiya K; Karashima T; Ikuyama S; Muta K; Kato K; Ibayashi H
    Endocrinol Jpn; 1985 Apr; 32(2):207-14. PubMed ID: 4042986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomifensine test does not differentiate hyperprolactinemia associated with and without radiologic abnormalities in the sella turcica.
    Canales ES; Cano C; Ablanedo J; Zárate A
    Horm Res; 1981; 15(4):213-7. PubMed ID: 6927819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomifensine in the diagnosis of hyperprolactinemia.
    Gullo D; Carmina E; Mogavero G; Perino A; Venezia R
    Acta Eur Fertil; 1981 Dec; 12(4):299-306. PubMed ID: 7342611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin lowering effect of amphetamine in normoprolactinemic subjects and in physiological and pathological hyperprolactinemia.
    DeLeo V; Cella SG; Camanni F; Genazzani AR; Müller EE
    Horm Metab Res; 1983 Sep; 15(9):439-43. PubMed ID: 6642414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benserazide and nomifensine in the diagnosis of prolactin-secreting pituitary adenomas.
    Pontiroli AE; Loda G; Roggia A; Scagliola P; Falsetti L
    Acta Endocrinol (Copenh); 1982 Oct; 101(2):171-9. PubMed ID: 7136447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indirect dopamine agonists and direct dopamine antagonists in the diagnosis of hyperprolactinemia].
    De Leo V; Massafra C; La Marca S; De Leo M; Venturi C; Urbani TM; Genazzani AR
    Boll Soc Ital Biol Sper; 1982 Aug; 58(16):1025-31. PubMed ID: 7138672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma prolactin levels in the inferior petrosal sinuses in various pituitary disorders during perihypophyseal phlebography.
    Lombardi G; Merola B; Miletto P; Colao A; De Chiara G; Iaccarino V; Spaziante R; Di Renzo G; Taglialatela M; Annunziato L
    Neuroendocrinology; 1987 Oct; 46(4):333-8. PubMed ID: 3670552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-related prolactin inhibitory effect of the new long-acting dopamine receptor agonist cabergoline in normal cycling, puerperal, and hyperprolactinemic women.
    Melis GB; Gambacciani M; Paoletti AM; Beneventi F; Mais V; Baroldi P; Fioretti P
    J Clin Endocrinol Metab; 1987 Sep; 65(3):541-5. PubMed ID: 3624413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomifensine-induced pregnancy in a hyperprolactinemic woman.
    Genazzani AR; De Leo V; Camanni F; Müller EE
    J Endocrinol Invest; 1982; 5(2):129-30. PubMed ID: 7096920
    [No Abstract]   [Full Text] [Related]  

  • 20. [Various aspects of dopaminergic function in patients with prolactin-secreting hypophyseal adenoma].
    De Leo V; Franchi F; Danero S; Ricci MG; La Marca S; Urbani TM; Pieroni ML; D'Antona N; Genazzani AR
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1883-9. PubMed ID: 6671047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.